The Program in Environmental and Translational Medicine combines clinical care with research to prevent, treat diseases caused from air pollution, water contamination, other causes.
UAB doctors can now employ a new procedure, using thermal energy, to open constricted airways in patients whose severe asthma is not controlled by medication.
UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.
A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.
UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.